Medical Properties Trust Stock Forecast, Price & News

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medical Properties Trust stock.
View analyst ratings for Medical Properties Trust or view top-rated stocks.

Wall Street analysts have given Medical Properties Trust a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medical Properties Trust wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Medical Properties Trust saw a increase in short interest in the month of May. As of May 28th, there was short interest totaling 14,530,000 shares, an increase of 21.9% from the May 13th total of 11,920,000 shares. Based on an average daily trading volume, of 3,730,000 shares, the short-interest ratio is currently 3.9 days. Currently, 2.5% of the shares of the company are short sold.
View Medical Properties Trust's Short Interest.

Medical Properties Trust is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Medical Properties Trust.

Medical Properties Trust, Inc. (NYSE:MPW) posted its quarterly earnings results on Thursday, April, 29th. The real estate investment trust reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.14. The real estate investment trust earned $362.77 million during the quarter, compared to analyst estimates of $347.16 million. Medical Properties Trust had a trailing twelve-month return on equity of 7.03% and a net margin of 39.02%. The company's revenue for the quarter was up 23.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 earnings per share.
View Medical Properties Trust's earnings history.

Medical Properties Trust's stock was trading at $19.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MPW stock has increased by 3.4% and is now trading at $20.27.
View which stocks have been most impacted by COVID-19.

Medical Properties Trust declared a quarterly dividend on Wednesday, May 26th. Investors of record on Thursday, June 17th will be given a dividend of $0.28 per share on Thursday, July 8th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 5.53%. The ex-dividend date is Wednesday, June 16th.
View Medical Properties Trust's dividend history.

Medical Properties Trust pays an annual dividend of $1.12 per share and currently has a dividend yield of 5.65%. MPW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Medical Properties Trust has been increasing its dividend for 6 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Medical Properties Trust is 71.34%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medical Properties Trust will have a dividend payout ratio of 60.87% next year. This indicates that Medical Properties Trust will be able to sustain or increase its dividend.
View Medical Properties Trust's dividend history.

Medical Properties Trust updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided EPS guidance of 1.720-1.760 for the period. The company issued revenue guidance of -.

9 Wall Street analysts have issued 12 month price targets for Medical Properties Trust's stock. Their forecasts range from $20.00 to $27.00. On average, they expect Medical Properties Trust's share price to reach $23.10 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price.
View analysts' price targets for Medical Properties Trust or view top-rated stocks among Wall Street analysts.

Some companies that are related to Medical Properties Trust include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Extra Space Storage (EXR), Ventas (VTR), CubeSmart (CUBE), Omega Healthcare Investors (OHI), Life Storage (LSI), Rayonier (RYN), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Health Care REIT (SBRA) and PotlatchDeltic (PCH).
View all of MPW's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Properties Trust investors own include AT&T (T), Verizon Communications (VZ), Energy Transfer (ET), Enterprise Products Partners (EPD), Omega Healthcare Investors (OHI), New Residential Investment (NRZ), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV) and Intel (INTC).

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

Medical Properties Trust's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.88%), Cohen & Steers Inc. (5.62%), Bank of New York Mellon Corp (2.06%), Geode Capital Management LLC (1.46%), Massachusetts Financial Services Co. MA (1.42%) and Dimensional Fund Advisors LP (1.39%). Company insiders that own Medical Properties Trust stock include Edward K Aldag Jr, Emmett E Mclean, G Steven Dawson, Holzgrefe Richard, James Kevin Hanna, Michael G Stewart and R Steven Hamner.
View institutional ownership trends for Medical Properties Trust.

MPW stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Daiwa Securities Group Inc., Mitsubishi UFJ Trust & Banking Corp, Standard Life Aberdeen plc, Bank of New York Mellon Corp, Morgan Stanley, Canada Pension Plan Investment Board, and Mutual of America Capital Management LLC. Company insiders that have sold Medical Properties Trust company stock in the last year include Edward K Aldag Jr, Emmett E Mclean, James Kevin Hanna, Michael G Stewart, and R Steven Hamner.
View insider buying and selling activity for Medical Properties Trust or view top insider-selling stocks.

MPW stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Millennium Management LLC, Nuveen Asset Management LLC, Cohen & Steers Inc., NFJ Investment Group LLC, Hazelview Securities Inc., Massachusetts Financial Services Co. MA, and Weiss Multi Strategy Advisers LLC. Company insiders that have bought Medical Properties Trust stock in the last two years include G Steven Dawson, and Holzgrefe Richard.
View insider buying and selling activity for Medical Properties Trust or or view top insider-buying stocks.

Shares of MPW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MPW stock can currently be purchased for approximately $20.27.

Medical Properties Trust has a market capitalization of $11.92 billion and generates $1.25 billion in revenue each year. The real estate investment trust earns $431.45 million in net income (profit) each year or $1.57 on an earnings per share basis.

Medical Properties Trust employs 106 workers across the globe.

The official website for Medical Properties Trust is www.medicalpropertiestrust.com.

Medical Properties Trust is headquartered at 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242.

Medical Properties Trust's mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The real estate investment trust can be reached via phone at (205) 969-3755 or via email at [email protected]